Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajiv Sarin

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Nature Reviews. Clinical Oncology|November 10, 2010
Ultra-targeted APBI using TARGIT--a cautionary noteRajiv Sarin
The Lancet. Oncology|June 6, 2006
Evidence-based clinicoradiobiological model for fractionationRajiv Sarin
Journal of Cancer Research and Therapeutics|February 18, 2010
From 3D to 5D radiotherapy: a blitzkrieg of DTH!Rajiv Sarin
Journal of Cancer Research and Therapeutics|November 14, 2007
Trends in basic, translational, epidemiological and therapeutic research in cancerRajiv Sarin
Journal of Cancer Research and Therapeutics|November 14, 2007
National Cancer Control Programme: beyond number gamesRajiv Sarin
Journal of Cancer Research and Therapeutics|November 14, 2007
A decade of discovery of BRCA1 and BRCA2: are we turning the tide against hereditary breast cancers?Rajiv Sarin
Nature Clinical Practice. Oncology|November 3, 2005
Partial-breast treatment for early breast cancer: emergence of a new paradigmRajiv Sarin
Journal of Cancer Research and Therapeutics|October 15, 2014
Big Data V4 for integrating patient reported outcomes and quality-of-life indices in clinical practiceRajiv Sarin
Journal of Cancer Research and Therapeutics|February 17, 2016
Global trends in specialist training, certification, and regulation of oncology practice and its implications for the developing worldRajiv Sarin
Journal of Cancer Research and Therapeutics|April 18, 2008
Criteria for deciding cost-effectiveness for expensive new anti-cancer agentsRajiv Sarin
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Nature Reviews. Clinical Oncology|November 10, 2010
Ultra-targeted APBI using TARGIT--a cautionary noteRajiv Sarin
The Lancet. Oncology|June 6, 2006
Evidence-based clinicoradiobiological model for fractionationRajiv Sarin
Journal of Cancer Research and Therapeutics|February 18, 2010
From 3D to 5D radiotherapy: a blitzkrieg of DTH!Rajiv Sarin
Journal of Cancer Research and Therapeutics|November 14, 2007
Trends in basic, translational, epidemiological and therapeutic research in cancerRajiv Sarin
Journal of Cancer Research and Therapeutics|November 14, 2007
National Cancer Control Programme: beyond number gamesRajiv Sarin
Journal of Cancer Research and Therapeutics|November 14, 2007
A decade of discovery of BRCA1 and BRCA2: are we turning the tide against hereditary breast cancers?Rajiv Sarin
Nature Clinical Practice. Oncology|November 3, 2005
Partial-breast treatment for early breast cancer: emergence of a new paradigmRajiv Sarin
Journal of Cancer Research and Therapeutics|October 15, 2014
Big Data V4 for integrating patient reported outcomes and quality-of-life indices in clinical practiceRajiv Sarin
Journal of Cancer Research and Therapeutics|February 17, 2016
Global trends in specialist training, certification, and regulation of oncology practice and its implications for the developing worldRajiv Sarin
Journal of Cancer Research and Therapeutics|April 18, 2008
Criteria for deciding cost-effectiveness for expensive new anti-cancer agentsRajiv Sarin
Pageof 16